Back
TransMedics Group Vs. Kymera Therapeutics Industry Stock Comparison
Sell
38
TMDX
TransMedics Group
Last Price:
81.98
Seasonality Move:
42.59%
Buy
62
KYMR
Kymera Therapeutics
Last Price:
46.17
Seasonality Move:
69.6%
Sell
38
TransMedics Group (TMDX)
is a Sell
Is TransMedics Group a Buy, Sell or Hold?
- The current TransMedics Group [TMDX] share price is $81.95. The Score for TMDX is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
- TMDX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
62
Kymera Therapeutics (KYMR)
is a Buy
Is Kymera Therapeutics a Buy, Sell or Hold?
- The current Kymera Therapeutics [KYMR] share price is $47.65. The Score for KYMR is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- KYMR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
TMDX Stock Price Chart
What is TransMedics Group's stock price today?
-
The TransMedics Group share price today is $81.95
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TMDX is experiencing selling pressure, which indicates risk of future bearish movement.
KYMR Stock Price Chart
What is Kymera Therapeutics's stock price today?
-
The Kymera Therapeutics share price today is $47.65
The current trend is moderately bearish and KYMR is experiencing slight selling pressure.
TMDX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -12.37 | Sell |
| Relative Strength Index (14 RSI): | 18.04 | Sell |
| Chaikin Money Flow: | -3855690 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (114.65 - 148.81) | Sell |
| Bollinger Bands (100): | (131.58 - 162.32) | Sell |
KYMR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.6 | Buy |
| Relative Strength Index (14 RSI): | 52.44 | Buy |
| Chaikin Money Flow: | -88534 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (44.05 - 49.09) | Buy |
| Bollinger Bands (100): | (36.61 - 48.91) | Buy |
TMDX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 113.75 | Sell |
| 20-day SMA: | 126.97 | Sell |
| 50-day SMA: | 145.08 | Sell |
| 200-day SMA: | 122.08 | Sell |
| 8-day EMA: | 109.65 | Sell |
| 20-day EMA: | 124.02 | Sell |
| 50-day EMA: | 137.04 | Sell |
| 200-day EMA: | 124.68 | Sell |
KYMR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 48.2 | Sell |
| 20-day SMA: | 46.01 | Buy |
| 50-day SMA: | 47.06 | Buy |
| 200-day SMA: | 39.57 | Buy |
| 8-day EMA: | 47.93 | Sell |
| 20-day EMA: | 47.19 | Buy |
| 50-day EMA: | 46.06 | Buy |
| 200-day EMA: | 39.32 | Buy |
TransMedics Group Earnings Growth & TMDX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.53 per share, and an increase next year of $0.63 per share.
Kymera Therapeutics Earnings Growth & KYMR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.23 per share, and a decrease next year of $0.47 per share.
TransMedics Group Technical Analysis
| Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 16 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Kymera Therapeutics Technical Analysis
| Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 16 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||